These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3438892)

  • 1. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.
    Tweeddale PM; Alexander F; McHardy GJ
    Thorax; 1987 Jul; 42(7):487-90. PubMed ID: 3438892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.
    Brand PL; Quanjer PH; Postma DS; Kerstjens HA; Koëter GH; Dekhuijzen PN; Sluiter HJ
    Thorax; 1992 Jun; 47(6):429-36. PubMed ID: 1496502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group.
    Kerstjens HA; Brand PL; Quanjer PH; van der Bruggen-Bogaarts BA; Koëter GH; Postma DS
    Thorax; 1993 Jul; 48(7):722-9. PubMed ID: 8153921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual Volume and Total Lung Capacity to Assess Reversibility in Obstructive Lung Disease.
    McCartney CT; Weis MN; Ruppel GL; Nayak RP
    Respir Care; 2016 Nov; 61(11):1505-1512. PubMed ID: 27555617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
    Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
    JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease.
    Biring MS; Madison S; Mohsenifar Z
    J Asthma; 2001 Sep; 38(6):495-500. PubMed ID: 11642416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
    Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
    Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator response in chronic obstructive pulmonary disease.
    Anthonisen NR; Wright EC
    Am Rev Respir Dis; 1986 May; 133(5):814-9. PubMed ID: 3706890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.
    Eliasson O; Degraff AC
    Am Rev Respir Dis; 1985 Oct; 132(4):858-64. PubMed ID: 4051321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of transfer factor to detect different bronchodilator responses in patients with chronic obstructive pulmonary disease.
    Izquierdo-Alonso JL; Sánchez-Hernández I; Fernández Francés J; Castelao Naval J; Carrillo Arias F; Gallardo Carrasco J
    Respiration; 1998; 65(4):282-8. PubMed ID: 9730794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
    Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. People with older age and lower FEV1%pred tend to have a smaller FVC than VC in pre-bronchodilator spirometry.
    Wang W; Ma D; Li T; Ying Y; Xiao W
    Respir Physiol Neurobiol; 2014 Apr; 194():1-5. PubMed ID: 24448311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.